Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001233471 | SCV001406068 | pathogenic | Familial aplasia of the vermis; Meckel-Gruber syndrome; Nephronophthisis | 2022-02-24 | criteria provided, single submitter | clinical testing | This variant has not been reported in the literature in individuals affected with CEP290-related conditions. This variant is not present in population databases (gnomAD no frequency). This sequence change creates a premature translational stop signal (p.Glu2307Thrfs*4) in the CEP290 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in CEP290 are known to be pathogenic (PMID: 16909394, 17345604, 20690115). ClinVar contains an entry for this variant (Variation ID: 960022). For these reasons, this variant has been classified as Pathogenic. |
Ocular Genomics Institute, |
RCV001376200 | SCV001573255 | likely pathogenic | Leber congenital amaurosis 10 | 2021-04-08 | criteria provided, single submitter | research | The CEP290 c.6919_6920del variant was identified in an individual with retinitis pigmentosa with a presumed recessive inheritance pattern. Through a review of available evidence we were able to apply the following criteria: PM2, PVS1. Based on this evidence we have classified this variant as Likely Pathogenic. |
Baylor Genetics | RCV003469425 | SCV004216692 | likely pathogenic | Bardet-Biedl syndrome 14 | 2023-11-17 | criteria provided, single submitter | clinical testing |